The roles of plant-derived nanovesicles in malignant tumours: A bibliometric analysis

Dandan Wang1, Zifan Mei1, Tingting Zhao1

  • 1Department of Breast and Thyroid Surgery, Southwest Hospital, Army Medical University, Chongqing, China.

Insights

Plant-derived nanovesicles (PDNVs) show promise for treating malignant tumors due to their safety and ability to induce cancer cell death. This review analyzes research on PDNVs for cancer therapy, offering insights for future treatments.

Area of Science:

  • Biotechnology
  • Oncology
  • Nanomedicine

Background:

  • Malignant tumors represent a significant global health challenge.
  • Plant-derived nanovesicles (PDNVs) offer a promising, biosafety-conscious approach to cancer treatment.
  • PDNVs exhibit mechanisms like cancer-selective apoptosis and cell cycle arrest.

Purpose of the Study:

  • To systematically review research progress on nanovesicles in malignant tumors.
  • To focus on plant-derived vesicles (PDVs) and their cancer treatment applications via bibliometric analysis.
  • To summarize PDNVs' biological functions, applications, and future potential in oncology.

Main Methods:

  • Bibliometric analysis of research on PDNVs in malignant tumors.
  • Identification and analysis of research trends by country, institution, author, and hotspots.
  • Synthesis of data on PDNVs' diverse biological functions and applications.

Main Results:

  • Analysis of global research landscape for PDNVs in cancer treatment.
  • Summary of PDNVs' roles, both independently and as carriers, in targeting malignant tumors.
  • Identification of key research areas and emerging trends in PDNVs for oncology.

Conclusions:

  • PDNVs are a significant area of research for novel cancer therapies.
  • Further investigation into PDNVs' mechanisms and applications can overcome challenges in tumor treatment.
  • This review provides a comprehensive overview and future directions for PDNVs in oncology.

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.6K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
1.9K